News Bio-Rad Laboratories, Inc.

Stocks

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 08:00:02 07/11/26 am AEDT			5-day change	1st Jan Change
381.57 ^USD	+3.41%		-0.74%	+25.93%

06/11	RBC Raises Price Target on Bio-Rad Laboratories to $440 From $390, Keeps Outperform Rating	MT
05/11	Bio-Rad Laboratories Q3 Adjusted Earnings, Revenue Rise	MT

All News

Mentions Relevance

06/11	RBC Raises Price Target on Bio-Rad Laboratories to $440 From $390, Keeps Outperform Rating	MT
05/11	Bio-Rad Laboratories Q3 Adjusted Earnings, Revenue Rise	MT
05/11	Bio-Rad Laboratories, Inc., Q3 2026 Earnings Call, Nov 04, 2026
05/11	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q3 Adjusted EPS $2.65 per Share, vs. FactSet Est of $2.23	MT
05/11	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q3 Revenue $656.4M, vs. FactSet Est of $649.9M	MT
05/11	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
05/11	Bio-Rad Reports Third-Quarter 2026 Financial Results	BU
05/11	Bio-Rad Laboratories, Inc. Reports Impairment of Purchased Intangibles for the Third Quarter Ended September 30, 2026	CI
30/10	Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference	BU
15/10	Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026	BU
25/09	Bio-Rad Laboratories, Inc. Presents at Bernstein Insights: Healthcare Leaders and Disruptors ? 3rd Annual Healthcare Forum, Sep-24-2026 08:50 AM
16/09	Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum	BU
10/09	Bio-Rad Laboratories, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 03:45 PM
31/08	Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference	BU
07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT
05/08	Bio Rad Laboratories : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
05/08	Bio-Rad Laboratories, Inc., Q2 2026 Earnings Call, Aug 04, 2026
05/08	Bio-Rad: Q2 Earnings Snapshot	AQ
05/08	Bio-Rad Laboratories Q2 Adjusted Earnings Rise, Revenue Falls	MT
05/08	Bio-Rad Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of 2026	CI
05/08	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M	MT
05/08	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.62 per Share, vs. FactSet Est of $1.75	MT
05/08	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
05/08	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI